Hepatitis E Virus Seroprevalence in HIV Positive Individuals in Shiraz, Southern Iran

Overview

Journal Iran J Microbiol

Publisher Tehran University of Medical Sciences

Specialty Infectious Diseases

Date 2015 Dec 2

PMID 26622971

Citations 9

Authors

Hassan Joulaei

Omid Rudgari

Nasrin Motazedian

Samaneh Gorji-Makhsous

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis in the world. It is usually a self-limited disease but may leads to the deaths of about 20% of pregnant women in developing countries. This study was conducted to determine the prevalence of HEV infection among HIV individuals .

Materials And Methods: This is a cross-sectional survey of HIV positive individuals in voluntary counselling and testing center of Shiraz in 2013 Using the systematic random sampling method, 158 patients enrolled for the research. They were asked about their age, gender, area of residence, marital status, number of children, education level, occupation, history of imprisonment, mode of HIV transmission, and viral hepatitis co-infection Three ml venous blood sample was drawn from each subject and transferred to the laboratory of voluntary counselling and testing center.

Results: The overall seroprevalence of hepatitis E was 26 (16.4%), where it increased significantly with age ranging from zero in subjects less than 30 years of age to 47.4% in those aged 50 years or older.

Conclusion: Co-infection of HIV positive individuals with HEV is an issue that should be of concern to health care providers.

Citing Articles

Hepatitis E Virus (HEV) Infection Among Immunocompromised Individuals: A Brief Narrative Review.

Alexandrova R, Tsachev I, Kirov P, Abudalleh A, Hristov H, Zhivkova T Infect Drug Resist. 2024; 17:1021-1040.

PMID: 38505248 PMC: 10948336. DOI: 10.2147/IDR.S449221.

Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study.

Zahedi M, Shafieipour S, Hayatbakhsh Abassi M, Pourjamali N, Nakhaie M, Charostad J Iran J Pathol. 2023; 18(2):125-133.

PMID: 37600571 PMC: 10439753. DOI: 10.30699/IJP.2023.551657.2870.

Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis.

Razavi-Amoli S, Alipour A Open Forum Infect Dis. 2022; 9(10):ofac477.

PMID: 36267256 PMC: 9578574. DOI: 10.1093/ofid/ofac477.

Seroprevalence of Hepatitis E Virus Infection in Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Qashqari F Medicina (Kaunas). 2022; 58(7).

PMID: 35888624 PMC: 9318471. DOI: 10.3390/medicina58070905.

Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran.

Shahriarirad R, Erfani A, Rastegarian M, Zeighami A, ArefKhah N, Ghorbani F Virol J. 2020; 17(1):109.

PMID: 32680534 PMC: 7368745. DOI: 10.1186/s12985-020-01384-0.

References

Taremi M, Gachkar L, MahmoudArabi S, Kheradpezhouh M, Khoshbaten M . Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran. East Mediterr Health J. 2007; 13(1):98-102. View

Assarehzadegan M, Shakerinejad G, Amini A, Rahim Rezaee S . Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis. 2007; 12(4):387-90. DOI: 10.1016/j.ijid.2007.09.015. View

Taremi M, Mohammad Alizadeh A, Ardalan A, Ansari S, Zali M . Seroprevalence of hepatitis E in Nahavand, Islamic Republic of Iran: a population-based study. East Mediterr Health J. 2008; 14(1):157-62. View

Ataei B, Nokhodian Z, Javadi A, Kassaian N, Shoaei P, Farajzadegan Z . Hepatitis E virus in Isfahan Province: a population-based study. Int J Infect Dis. 2008; 13(1):67-71. DOI: 10.1016/j.ijid.2008.03.030. View

Colson P, Dhiver C, Gerolami R . Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin Microbiol Infect. 2008; 14(12):1176-80. DOI: 10.1111/j.1469-0691.2008.02102.x. View

Curry J, Adams N, Crum-Cianflone N . Acute hepatitis E virus infection in an HIV-infected person in the United States. Ann Intern Med. 2009; 150(3):226-7. PMC: 2720044. DOI: 10.7326/0003-4819-150-3-200902030-00028. View

Mamun-Al-Mahtab , Rahman S, Khan M, Karim F . HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh. J Health Popul Nutr. 2009; 27(1):14-9. PMC: 2761807. DOI: 10.3329/jhpn.v27i1.3314. View

Saffar M, Farhadi R, Ajami A, Khalilian A, Babamahmodi F, Saffar H . Seroepidemiology of hepatitis E virus infection in 2-25-year-olds in Sari district, Islamic Republic of Iran. East Mediterr Health J. 2009; 15(1):136-42. View

Dalton H, Bendall R, Keane F, Tedder R, Ijaz S . Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009; 361(10):1025-7. DOI: 10.1056/NEJMc0903778. View

10.

Kuniholm M, Labrique A, Nelson K . Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E virus?. Clin Infect Dis. 2010; 50(11):1545-6. DOI: 10.1086/652716. View

11.

Sellier P, Mazeron M, Tesse S, Badsi E, Evans J, Magnier J . Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels. Virol J. 2011; 8:171. PMC: 3104369. DOI: 10.1186/1743-422X-8-171. View

12.

Kenfak-Foguena A, Schoni-Affolter F, Burgisser P, Witteck A, Darling K, Kovari H . Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis. 2011; 17(6):1074-8. PMC: 3358194. DOI: 10.3201/eid/1706.101067. View

13.

Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J . Hepatitis E virus coinfection in patients with HIV infection. HIV Med. 2011; 13(1):83-8. DOI: 10.1111/j.1468-1293.2011.00942.x. View

14.

Crum-Cianflone N, Curry J, Drobeniuc J, Weintrob A, Landrum M, Ganesan A . Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis. 2012; 18(3):502-6. PMC: 3309581. DOI: 10.3201/eid1803.111278. View

15.

Raoofi R, Nazer M, Pournia Y . Seroepidemiology of hepatitis E virus in Western Iran. Braz J Infect Dis. 2012; 16(3):302-3. View

16.

Caron M, Bouscaillou J, Kazanji M . Acute risk for hepatitis E virus infection among HIV-1-positive pregnant women in central Africa. Virol J. 2012; 9:254. PMC: 3495846. DOI: 10.1186/1743-422X-9-254. View

17.

Feldt T, Sarfo F, Zoufaly A, Phillips R, Burchard G, van Lunzen J . Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon. J Clin Virol. 2013; 58(1):18-23. DOI: 10.1016/j.jcv.2013.05.004. View

18.

Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi S . Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol. 2013; 5(2):172-6. PMC: 3696855. View

19.

Ramezani A, Velayati A, Khorami-Sarvestani S, Eslamifar A, Mohraz M, Banifazl M . Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran. Int J STD AIDS. 2013; 24(10):769-74. DOI: 10.1177/0956462413484457. View

20.

Mateos-Lindemann M, Diez-Aguilar M, Galdamez A, Galan J, Moreno A, Perez-Gracia M . Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol. 2013; 86(1):71-4. DOI: 10.1002/jmv.23804. View